News
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year ...
Drugmaker acquires DNA testing firm and gains access to massive genetic database ● Consumer genome services to continue; ...
Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results